Skip to content

Non Pharmacological Therapy of Abhyangam and sunbathing, diversified diet, Pranayam and Yogasana as an adjuvant in the management of COPD

Non Pharmacological Therapy (NPT consisting of Abhyangam and sunbathing, diversified diet, Pranayam and Yogasana) as an adjuvant in the management of COPD - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/078962
Enrollment
40
Registered
2025-01-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: abhyangam and sunbathing: Select a suitable oil based on Patients body type or dosha. Find a warm, quiet, and clean area where the patient can comfortably lie down. Gently warm the o

Sponsors

ESIC Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed cases of COPD. 2. Stage I, II and III COPD, clinically stable for at least 3 months. 3. Sufficient cognitive function to follow instructions for spirometry. 4. Able to walk without aid. 5. Willingness to undergo the prescribed modified lifestyle protocol of NPT 6. Provide informed consent.

Exclusion criteria

Exclusion criteria: Exclusion 1.Myocardial infarction within last 3 months 2.Asthma 3.Recent surgery of thorax, abdomen, head, eyes or ear. 4. Haemoptysis. 5.Severe hypertension (BP more than 200/120 mm Hg). 6.Recurrent angina within the previous six months. 7.Recent injury or neuromuscular conditions interfering with exercise tests. 8.Current Smokers. 9.Active Tuberculosis infection.

Design outcomes

Primary

MeasureTime frame
Objective Outcome Parameters: 1. The efficacy of the NPT regimen will be evaluated based on various objective measures, including vital signs such as blood pressure (BP), pulse rate (PR), respiratory rate (RR), and oxygen saturation (SpO2), as well as findings from chest examinations. 2. Pulmonary function tests, including forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and FEV1/FVC ratio. We will assess lung functions using spirometry. 3. Laboratory investigations will monitor changes in complete blood count (CBC), liver function tests (LFT), kidney function tests (KFT), serum electrolyte levels, random blood sugar (RBS), high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), vitamin D levels, D-dimer, and lipid profile. In addition, the occurrence of respiratory infection will be evaluated to assess the impact of the intervention.Timepoint: 12 weeks objective Outcome Parameters

Secondary

MeasureTime frame
Subjective Outcome Parameters 1. Subjective outcomes will focus on the patients perception of their COPD symptoms and overall well-being. 2. Dyspnoea severity will be assessed using the Modified Medical Research Council (MMRC) Dyspnoea Scale. Health related quality of life will be measured using the St. Georges Respiratory Questionnaire (SGRQ) and the COPD Assessment Test (CAT).Timepoint: 12 wks;3. Mental health status will be evaluated using the WHO (Five) Well Being Index, while sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). These subjective measures will provide insights into the impact of the NPT regimen on symptom burden, functional status, mental health, and sleep disturbances experienced by COPD patients.Timepoint: 12 weeks

Countries

India

Contacts

Public ContactDrMona Jha

ESIC Medical College Hospital Faridabad

drmksen@yahoo.com9968306997

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026